|
|
Article: News Analysis: Big Pharma mergers: a quick fix, not strategic
- Article from:
- Xinhua News Agency
- Article date:
- March 14, 2009
CopyrightCopyright 2009 Xinhua News Agency. Provided by ProQuest LLC. (Hide copyright information)
|
News Analysis: Big Pharma mergers: a quick fix, not strategic
BEIJING, March 14 (Xinhua) -- Swiss pharmaceutical giant Roche on
Thursday announced plans to buy out California-based biotech pioneer
Genetech for 46.8 billion U.S. dollars. The transaction is the
latest megadeal in a burst of Big Pharma mergers.
What will consolidation bring to the industry? Will the tie-up
lead to an upsurge in new drugs? Is acquisition a panacea for
drugmakers facing increased cost pressures as key patents expire?
BURST OF HUGE MERGERS
Pfizer Inc., the world's largest drugmaker, said on Jan. 27 that
it was buying rival Wyeth for 68 billion dollars in a deal to boost
its revenue and diversification.
Pfizer ...